A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
10/2/2026
BreakingDealsGlaucomaIOL
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of common stock in Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 milli...
10/2/2026
BreakingDealsOptometry
MyEyeDr. Acquires Optometry Division of EyeCare Partners
MyEyeDr., of Vienna, Virginia, announced Sept. 28 that it would acquire the optometry division of EyeCare Partners, of St. Louis, Missouri. The deal covers the optometric brands of Clarkson Eyecare...
10/2/2026
BreakingDry EyePharmaRegulation
Aldeyra to File Formal Dispute with US FDA over Reproxalap Rejection
Aldeyra Therapeutics reported Sept. 29 that it would submit a formal dispute resolution request with the US FDA over the rejection of reproxalap, a topical treatment candidate for dry eye disease. ...
10/2/2026
BreakingGene TherapyRegulationRetina
Ocugen Gains Provisional Approval in Bahamas to Treat RP Patients with OCU400
Ocugen announced Sept. 25 that OCU400, its subretinal modifier gene therapy candidate targeting retinitis pigmentosa (RP), had been granted provisional approval and priority designation by regulato...
10/2/2026
BreakingCataractIndustryRefractiveRetinaSurgical
Sightpath Medical Adds Retinal Equipment to Mobile Offering
Sightpath Medical reported Sept. 22 that it now delivers retinal equipment for ophthalmic surgery. The company’s mobile services for retina specialists include delivery of a vitrectomy platform in ...
10/2/2026
BreakingCell TherapyChinaClinical TrialRetina
iRegene’s RP Cell Therapy Candidate Gets Green Light for Clinical Trials in China, US
China’s iRegene Therapeutics announced Sept. 29 that its cell therapy candidate targeting retinitis pigmentosa (RP) gained authorization from regulators to enter clinical trials in both China and t...
10/2/2026
BreakingCataractIOLPremiumSurgical
InSightVR IOL Simulator Linked to Increased Premium Lens Selection, Better Understanding
GreenMan Vision, of West Fargo, North Dakota, reported Sept. 21 that its InSightVR IOL simulator was associated with several key benefits in a study published Sept. 5 in the journal Patient Prefere...
10/2/2026
BreakingCornealIndustryPharma
Claris Bio Establishes Corporate Headquarters in San Francisco
Claris Bio reported Sept. 24 that it had moved its corporate headquarters from Jersey City, New Jersey, to San Francisco, California. Its new home is at 701 Gateway Blvd., Suite 250, South San Fran...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.